Shandong Anhong Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is AFATINIB DIMALEATE, with a corresponding US DMF Number 33080.
Remarkably, this DMF maintains an Active status since its submission on February 11, 2019, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of March 21, 2019, and payment made on February 12, 2019, indicating their dedication to facilitating drug approvals, Categorized as Type II